Latest News

Date Title Topic
30 Jun 2017 ESMO/ACF Patient Guide in Sarcoma Now Available Also in Spanish
30 Jun 2017 FDA Approves Rituximab Plus Hyaluronidase Combination for Treatment of FL, DLBCL and CLL Haematologic malignancies - Anticancer agents & Biologic therapy
30 Jun 2017 World GI 2017 Press Release: Liquid Biopsies: A Non-invasive Look at Treatment Response Gastrointestinal cancers
30 Jun 2017 World GI 2017 Press Release: Zoning in on Specifics of Mediterranean Diet for Colorectal Health Gastrointestinal cancers
28 Jun 2017 ESMO Essentials for Clinicians: Gynaecological Tumours
28 Jun 2017 Solange Peters elected ESMO President 2020-2021
28 Jun 2017 EMA Recommends Extensions of Therapeutic Indications for Regorafenib Gastrointestinal cancers - Anticancer agents & Biologic therapy
eUpdate – Treatment Recommendation
eUpdate – Treatment Algorithms
27 Jun 2017 EMA Recommends Granting a Marketing Authorisation for Tivozanib Hydrochloride Monohydrate Genitourinary cancers - Anticancer agents & Biologic therapy
eUpdate – Treatment Recommendations
26 Jun 2017 EMA Recommends Granting a Marketing Authorisation for Ribociclib Breast cancer - Anticancer agents & Biologic therapy
23 Jun 2017 Annals of Oncology
23 Jun 2017 FDA Grants Regular Approval to Dabrafenib and Trametinib Combination for Metastatic NSCLC with BRAF V600E Mutation Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
22 Jun 2017 Efficacy Results From I-SPY 2 Trial Show Improved Outcomes with Combination Pembrolizumab Plus Standard Neoadjuvant Therapy for High-Risk Breast Cancer Breast cancer - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy